<!DOCTYPE html>
<html lang="en-us">
    <head>
		
		
		<meta charset="UTF-8">
		<meta name="viewport" content="width=device-width, initial-scale=1.0">

		<title> &middot; The Chen-Liu Lab</title>

		
		<link rel="stylesheet" href="/css/style.css">
		<link rel="stylesheet" href="/css/fonts.css">
		
		<link rel="icon" href="/favicon.ico"/>
		<link rel="icon" type="image/png" sizes="32x32" href="/images/favicon-32x32.png">
		<link rel="icon" type="image/png" sizes="16x16" href="/images/favicon-16x16.png">
		<link rel="apple-touch-icon" sizes="180x180" href="/images/apple-touch-icon.png">

		
		<link href="" rel="alternate" type="application/rss+xml" title="The Chen-Liu Lab" />
	</head>

    <body>
        		<nav class="nav">
			<div class="nav-container">
				<a href="/">
					
						<h2 class="nav-title">The Chen-Liu Lab</h2>
					
				</a>
				<ul>
    
    
        <li>
            <a href="/home/">
                
                <span>Home</span>
                
            </a>
        </li>
    
        <li>
            <a href="/publications/">
                
                <span>Publications</span>
                
            </a>
        </li>
    
        <li>
            <a href="/people/">
                
                <span>People</span>
                
            </a>
        </li>
    
        <li>
            <a href="/events/">
                
                <span>Events</span>
                
            </a>
        </li>
    
        <li>
            <a href="/monthly_pictures/">
                
                <span>Fun</span>
                
            </a>
        </li>
    
        <li>
            <a href="/contact/">
                
                <span>Contact</span>
                
            </a>
        </li>
    
        <li>
            <a href="/events/">
                
                <span></span>
                
            </a>
        </li>
    
</ul>
			</div>
		</nav>

        

<main>
	<div class="post">
		<div class="post-info">
    <span></span>
        
</div>

		<h1 class="post-title"></h1>


		

		<p><b><font size=7 face="Times New Room"><center>The Chen-Liu Laboratory</center></font></b></p>
<hr>
<p><font size=5 color="#696969"><center>Investigate cancer as a biology and a treatment target</font></center></p>
<hr>
<p><b><font size=6 face="Times New Room"><center>Principal Investigators</font></b></center></p>
<table style="margin-left: auto; margin-right: auto;"><tbody><tr><td><a href="/cc"></a><div style="position:relative;top:10px;left:80px;width:400px;height:100px"><a href="/cc"><img src="/images/CC.png" align="left"></a></div>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size="5" color="#4169E1"><a href="/cc">Chong Chen, PhD</a></font><ul><li>PhD, University of Michigan-Ann Arbor (2009)</li>
<li>BS, Peking University (1999)</li></ul></td><td><a href="/liuyu"><div style="position:relative;top:10px;right:80px;width:400px;height:100px"><img src="/images/LY.png" align="right"></div></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size="5" color="#4169E1"><a href="/liuyu">Yu Liu, PhD</a></font><ul><li>PhD, Albert Einstein College of Medicine (2008)</li>
<li>BS, Beijing Normal University (1997)</li></ul></td></tr></tbody></table>
<p><b><font size=6 face="Times New Room">Research Interests</font></b></p>
<p>The Chen-Liu lab aims to understand the biology of cancer and identify new therapeutic targets for treatment. We develop and apply precision cancer models, genome editing, organoid culturing, multi-omics analyses, bioinformatics, and clinical studies to build a full technique chain from basic cancer studies to clinic oncology practice. We are proud of being a diverse and collaborating group of students, postdoc, physicians, staff, and faculty. Our current research focus on:</p>
<p><b><font size=4>1. Precision cancer models</font></b></p>
<p>Taking advantage of recent progress in cancer genomics, genome editing, and organoid culturing, we develop a multiplexing strategy to create primary, orthotopic, and drivers-defined cancer models in mice. These precision cancer models can reproduce the whole process of tumorigenesis and recapitulate the pathology of human malignancies. So far, we have generated such precision animal models for lung cancer (NSCLC and SCLC), esophageal cancers (ESCC and EAC), gastric cancers, bladder cancer, nasopharyngeal cancer, and blood cancers (AML and lymphoma).</p>
<p><b><font size=4>2. Tumor initiation and progression</font></b></p>
<p>With these models, we investigate the detailed molecular mechanisms underlying tumorigenesis. We are especially interested in potential functional roles of human cancer-associated copy number variations (CNVs), a very much but less studied feature of human cancers. We have validated chromosome 17p loss as a driver for lymphoma and leukemia (nature 2016). We identify new tumor suppressors and oncogenes on CNVs, such as ALOX15B and PHF23 on chromosome 17p (nature 2016 and cancer discovery 2021) and KMT2C on chromosome 7q (cancer cell 2014). Interestingly, many of these genes are epigenetic factors. We explore the detailed molecular mechanisms of the epigenetic reprogramming in tumorigenesis.</p>
<p><b><font size=4>3. Acquired chemo- and immunotherapy resistance</font></b></p>
<p>We apply our models and collaborate with physicians from the West China Hospital to dissect the molecular mechanisms underlying acquired resistance for cancer treatments. Ongoing projects includes studies on the acquired resistance to cisplatin-based chemotherapies in SCLC and MIBC and to immunotherapies in various types of cancers.</p>
<p><b><font size=6 face="Times New Room">Selected publications</font></b></p>
<table>
	<tr>
		<td>
					<div style="position:relative;top: 30px;left:17px;width:200px;height:220px">	
	<img src="/images/2022cc.jpg" align="left" />
</div>
		</td>
		<td>
			<a href="/publication/2022cc">
<div style="position:relative;top:30px;left:20px;width:550px;height:220px">
<font size=4>
<p><strong>Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer</strong></p>
</font>
<font size=2>
Wang M, Chen X, Tan P, Wang Y, Pan X, Lin T, Jiang Y. et al. Cancer Cell (2022). https://doi.org/10.1016/j.ccell.2022.08.010
 </font>
	</div>
	</a>
		</td>
	</tr>
<tr>
		<td>
					<div style="position:relative;top: 30px;left:17px;width:200px;height:220px">	
	<img src="/images/nc2022.jpg" align="left" />
</div>
		</td>
		<td>
			<a href="/publication/nc2022">
<div style="position:relative;top:30px;left:20px;width:550px;height:220px">
<font size=4>
<p><strong>KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming</strong></p>
</font>
<font size=2>
Na F, Pan X, Chen J, Chen X, Wang M, Chi P, You L. et al. Nature Cancer (2022). https://doi.org/10.1038/s43018-022-00361-6
 </font>
	</div>
	</a>
		</td>
	</tr>
<tr>
		<td>
					<div style="position:relative;top: -15px;left:17px;width:200px;height:220px">	
	<img src="/images/sttt_pxy.jpg" align="left" />
</div>
		</td>
		<td>
			<a href="/publication/sttt2022">
<div style="position:relative;top:10px;left:20px;width:550px;height:220px">
<font size=4>
<p><strong>Identifying a confused cell identity for esophageal squamous cell carcinoma</strong></p>
</font>
<font size=2>
Pan X, Wang J, Guo L, Na F, Du J, Chen X, Zhong A, Zhao L, Zhang L, Zhang M, Wan X, Wang M, Liu H, Dai S, Tan P, Chen J, Liu Y, Hu B, Chen C. Signal Transduct Target Ther. 2022 Apr 13;7(1):122. doi: 10.1038/s41392-022-00946-8. PMID: 35418165.
 </font>
	</div>
	</a>
		</td>
	</tr>
<tr>
		<td>
					<div style="position:relative;left:17px;width:200px;height:220px">	
	<img src="/images/mosaic2.jpg" align="left" />
</div>
		</td>
		<td>
			<a href="/publication/mosaic">
<div style="position:relative;top:45px;left:20px;width:550px;height:220px">
<font size=4>
<p><strong>Mosaic loss of chromosome Y promotes leukemogenesis and clonal hematopoiesis</strong></p>
</font>
<font size=2>
Zhang Q, Zhao L, Yang Y, Li S, Liu Y, Chen C. JCI Insight. 2022 Feb 8;7(3):e153768. doi: 10.1172/jci.insight.153768. PMID: 35132955; PMCID: PMC8855789.
 </font>
	</div>
	</a>
		</td>
	</tr>
<tr>
		<td>
					<div style="position:relative;left:5px;width:200px;height:200px">	
	<img src="/images/epihead.jpg" align="left" />
</div>
		</td>
		<td>
			<a href="/publication/epigenetic">
<div style="position:relative;top:20px;left:20px;width:550px;height:180px">
<font size=4>
<p><strong>An Epigenetic Mechanism Underlying Chromosome 17p Deletion-Driven Tumorigenesis</strong></p>
</font>
<font size=2>
Chen M, Chen X, Li S, Pan X, Gong Y, Zheng J, Xu J, Zhao C, Zhang Q, Zhang S, Qi L, Wang Z, Shi K, Ding BS, Xue Z, Chen L, Yang S, Wang Y, Niu T, Dai L, Lowe SW, Chen C, Liu Y. Cancer Discov. 2021 Jan;11(1):194-207. doi: 10.1158/2159-8290.CD-20-0336. Epub 2020 Sep 25. PMID: 32978226; PMCID: PMC8591992.</font>
	</div>
	</a>
		</td>
	</tr>
<tr>
		<td>
					<div style="position:relative;top:30px;left:10px;width:200px;height:220px">	
	<img src="/images/Nivolumab.jpg" align="left" />
</div>
		</td>
		<td>
			<a href="/publication/nivolumab">
<div style="position:relative;top:20px;left:20px;width:550px;height:220px">
<font size=4>
<p><strong>Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults</strong></p>
</font>
<font size=2>
Liu P, Pan X, Chen C, Niu T, Shuai X, Wang J, Chen X, Liu J, Guo Y, Xie L, Wu Y, Liu Y, Liu. Blood. 2020 Mar 12;135(11):826-833. doi: 10.1182/blood.2019003886. PMID: 31914172.
 </font>
	</div>
	</a>
		</td>
	</tr>
<tr>
		<td>
		<div style="position:relative;top: 20px;left:17px;width:200px;height:180px">	
	<img src="/images/drug.jpg" align="left" />
</div>
		</td>
		<td>
			<a href="/publication/drug">
<div style="position:relative;top:15px;left:20px;width:550px;height:210px">
<font size=4>
<p><strong>Epigenetic drug library screening identified an LSD1 inhibitor to target UTX-deficient cells for differentiation therapy</strong></p>
</font>
<font size=2>
Wu B, Pan X, Chen X, Chen M, Shi K, Xu J, Zheng J, Niu T, Chen C, Shuai X, Liu Y. Signal Transduct Target Ther. 2019 Apr 26;4:11. doi: 10.1038/s41392-019-0040-2. PMID: 31044091; PMCID: PMC6483994.
 </font>
	</div>
	</a>
		</td>
	</tr>
<tr>
		<td>
					<div style="position:relative;width:220px;height:200px;top:20px">	
	<img src="/images/deletions.jpg" align="left" />
</div>
		</td>
		<td>
			<a href="/publication/deletions">
			<div style="position:relative;top: 20px;left:20px;width:550px;height:100px">
<font size=4>
<p><strong>Deletions linked to TP53 loss drive cancer through p53-independent mechanisms</strong></p>
</font>
<font size=2>
Liu Y, Chen C, Xu Z, Scuoppo C, Rillahan CD, Gao J, Spitzer B, Bosbach B, Kastenhuber ER, Baslan T, Ackermann S, Cheng L, Wang Q, Niu T, Schultz N, Levine RL, Mills AA, Lowe SW. Nature. 2016 Mar 24;531(7595):471-475. doi: 10.1038/nature17157. Epub 2016 Mar 16. PMID: 26982726; PMCID: PMC4836395.</font>
</a>
	</div>
		</td>
	</tr>
</table>
<script async src="//busuanzi.ibruce.info/busuanzi/2.3/busuanzi.pure.mini.js"></script>
<center><span id="busuanzi_container_site_pv"><font face="Gabriola" size=5><i>Pageview </i>: </font><span id="busuanzi_value_site_pv"></span></span></center>

		
	</div>

	<div class="pagination">
		<a href="/monthly_pictures/" class="left arrow">&#8592;</a>
		<a href="/events/" class="right arrow">&#8594;</a>

		<a href="#" class="top">Top</a>
	</div>
</main>


        		<footer>
			
			<span>
			&copy; <time datetime="2025-02-06 14:24:50.9725273 &#43;0800 CST m=&#43;0.099595701">2025</time> . Made with <a href='https://gohugo.io'>Hugo</a> using the <a href='https://github.com/EmielH/tale-hugo/'>Tale</a> theme.
			</span>
		</footer>

    </body>
</html>
